Drug Research
Samsung Biologics to add mRNA vaccine drug substance manufacturing...
Samsung Biologics , a leading global CDMO providing end-to-end contract development and manufacturing services, announced its plans to add mRNA vaccine drug substance (DS) manufacturing...
Drug Research
Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol...
Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company. This expanded collaboration...
Drug Research
Agilex Biolabs Toxicology Tapped for SARS-CoV-2 Vaccine Research
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and...
Drug Research
Dr. Reddy’s Laboratories enters into a Voluntary Licensing Agreement...
Dr. Reddy's Laboratories Ltd. announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company ("Lilly") for the manufacture...
Drug Research
Novavax Covid-19 vaccine provides cross-protection against B.1.351 variant
The protein-based vaccine candidate NVX-CoV2373 is made from the genetic sequence of the first SARS-CoV-2 strain. It is adjuvanted with the company’s saponin-based Matrix-M to...
Drug Research
3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to...
3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organisation CDMO specialized in the process development and GMP manufacturing of biologics and Buzzard Pharmaceuticals, a Swedish...
Drug Research
Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential...
Vectura Group plc, an industry leading inhalation CDMO, and Inspira Pharmaceuticals Limited, a new UK-based company focused on developing therapies for respiratory and infectious diseases,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.